Fortress Biotech, based in Bay Harbor Islands, Florida, specializes in novel pharmaceuticals with seven marketed products and over 25 developmental programs across oncology, rare diseases, and gene therapy. The company went public in November 2011 and has 186 employees.
FBIO has been in the news recently: New Fortress Energy Inc. successfully completed a $1.5 billion private exchange of senior secured notes, part of a total issuance of $2.7 billion due in 2029. Fortress Solutions appointed Dan Lakey as Chief Revenue Officer to enhance growth and expand the FortressONE platform in key markets.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
